Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Regression of Recurrent Spinal Cord High-Grade Glioma After Convection-Enhanced Delivery of Nimustine Hydrochloride: Case Reports and Literature Review.

Endo T, Inoue T, Sugiyama S, Saito R, Tominaga T.

Oper Neurosurg (Hagerstown). 2019 Aug 14. pii: opz172. doi: 10.1093/ons/opz172. [Epub ahead of print]

PMID:
31414134
2.

Convection-enhanced delivery of a hydrophilic nitrosourea ameliorates deficits and suppresses tumor growth in experimental spinal cord glioma models.

Ogita S, Endo T, Sugiyama S, Saito R, Inoue T, Sumiyoshi A, Nonaka H, Kawashima R, Sonoda Y, Tominaga T.

Acta Neurochir (Wien). 2017 May;159(5):939-946. doi: 10.1007/s00701-017-3123-2. Epub 2017 Feb 28.

PMID:
28247160
3.

Regression of recurrent glioblastoma infiltrating the brainstem after convection-enhanced delivery of nimustine hydrochloride.

Saito R, Sonoda Y, Kumabe T, Nagamatsu K, Watanabe M, Tominaga T.

J Neurosurg Pediatr. 2011 May;7(5):522-6. doi: 10.3171/2011.2.PEDS10407.

PMID:
21529193
4.

Safety and feasibility of convection-enhanced delivery of nimustine hydrochloride co-infused with free gadolinium for real-time monitoring in the primate brain.

Sugiyama S, Saito R, Nakamura T, Yamashita Y, Yokosawa M, Sonoda Y, Kumabe T, Watanabe M, Tominaga T.

Neurol Res. 2012 Jul;34(6):581-7. doi: 10.1179/1743132812Y.0000000050. Epub 2012 Jun 16.

PMID:
22709625
5.

Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.

Sugiyama S, Yamashita Y, Kikuchi T, Saito R, Kumabe T, Tominaga T.

J Neurooncol. 2007 Mar;82(1):41-7. Epub 2006 Sep 20.

PMID:
17031554
6.

Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts.

Sugiyama S, Yamashita Y, Kikuchi T, Sonoda Y, Kumabe T, Tominaga T.

Neurol Res. 2008 Nov;30(9):960-7. doi: 10.1179/174313208X331581. Epub 2008 Jul 30.

PMID:
18671903
7.

Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.

Sewing ACP, Lagerweij T, van Vuurden DG, Meel MH, Veringa SJE, Carcaboso AM, Gaillard PJ, Peter Vandertop W, Wesseling P, Noske D, Kaspers GJL, Hulleman E.

J Neurosurg Pediatr. 2017 May;19(5):518-530. doi: 10.3171/2016.9.PEDS16152. Epub 2017 Feb 17.

PMID:
28291423
8.

Concentration rather than dose defines the local brain toxicity of agents that are effectively distributed by convection-enhanced delivery.

Zhang R, Saito R, Mano Y, Kanamori M, Sonoda Y, Kumabe T, Tominaga T.

J Neurosci Methods. 2014 Jan 30;222:131-7. doi: 10.1016/j.jneumeth.2013.11.004. Epub 2013 Nov 20.

PMID:
24269253
9.

Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.

Anderson RC, Kennedy B, Yanes CL, Garvin J, Needle M, Canoll P, Feldstein NA, Bruce JN.

J Neurosurg Pediatr. 2013 Mar;11(3):289-95. doi: 10.3171/2012.10.PEDS12142. Epub 2012 Dec 14.

PMID:
23240851
10.

Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals.

Wang W, Sivakumar W, Torres S, Jhaveri N, Vaikari VP, Gong A, Howard A, Golden EB, Louie SG, Schönthal AH, Hofman FM, Chen TC.

Neurosurg Focus. 2015 Mar;38(3):E8. doi: 10.3171/2015.1.FOCUS14743.

PMID:
25727230
11.

Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.

Lidar Z, Mardor Y, Jonas T, Pfeffer R, Faibel M, Nass D, Hadani M, Ram Z.

J Neurosurg. 2004 Mar;100(3):472-9.

PMID:
15035283
12.

Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma.

Parney IF, Kunwar S, McDermott M, Berger M, Prados M, Cha S, Croteau D, Puri RK, Chang SM.

J Neurosurg. 2005 Feb;102(2):267-75.

PMID:
15739554
13.

Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.

Weller M, Müller B, Koch R, Bamberg M, Krauseneck P; Neuro-Oncology Working Group of the German Cancer Society.

J Clin Oncol. 2003 Sep 1;21(17):3276-84.

PMID:
12947063
14.

Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment.

Zhou Z, Singh R, Souweidane MM.

Curr Neuropharmacol. 2017;15(1):116-128.

15.

Properties of convective delivery in spinal cord gray matter: laboratory investigation and computational simulations.

Endo T, Fujii Y, Sugiyama SI, Zhang R, Ogita S, Funamoto K, Saito R, Tominaga T.

J Neurosurg Spine. 2016 Feb;24(2):359-366. doi: 10.3171/2015.5.SPINE141148. Epub 2015 Oct 30.

PMID:
26516661
16.

Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats.

Degen JW, Walbridge S, Vortmeyer AO, Oldfield EH, Lonser RR.

J Neurosurg. 2003 Nov;99(5):893-8.

PMID:
14609170
17.

Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.

Sewing AC, Caretti V, Lagerweij T, Schellen P, Jansen MH, van Vuurden DG, Idema S, Molthoff CF, Vandertop WP, Kaspers GJ, Noske DP, Hulleman E.

J Neurosci Methods. 2014 Dec 30;238:88-94. doi: 10.1016/j.jneumeth.2014.09.020. Epub 2014 Sep 27.

PMID:
25263805
18.

Intratumoral microinfusion of nimustine (ACNU) for recurrent glioma.

Wakabayashi T, Yoshida J, Mizuno M, Kajita Y.

Brain Tumor Pathol. 2001;18(1):23-8.

PMID:
11517970
19.

Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors.

Yang W, Huo T, Barth RF, Gupta N, Weldon M, Grecula JC, Ross BD, Hoff BA, Chou TC, Rousseau J, Elleaume H.

J Neurooncol. 2011 Feb;101(3):379-90. doi: 10.1007/s11060-010-0272-z. Epub 2010 Jun 25. Erratum in: J Neurooncol. 2011 Feb;101(3):391.

20.

Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.

Saito R, Tominaga T.

Neurol Med Chir (Tokyo). 2017 Jan 15;57(1):8-16. doi: 10.2176/nmc.ra.2016-0071. Epub 2016 Dec 15. Review.

Supplemental Content

Support Center